Skip to Main Content

Paper Details

Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Nat Genet
228
2014
Angiosarcoma, Arg707Gln, PLCG1, PLCG1 mutations, PTPRB, angiogenesis signaling genes, angiosarcoma, chronic lymphoedema, endothelial phosphatase PTPRB, malignancy, p.Arg707Gln, tumors, tyrosine, tyrosine kinases, vascular growth factor tyrosine kinases
Author NameAffiliation
Patrick S TarpeyWellcome Trust Sanger Institute
Inigo MartincorenaWellcome Trust Sanger Institute
Peter Van LooWellcome Trust Sanger Institute
Peter Van Loo
Gunes GundemWellcome Trust Sanger Institute
David C WedgeWellcome Trust Sanger Institute
Manasa RamakrishnaWellcome Trust Sanger Institute
Susanna L CookeWellcome Trust Sanger Institute
Hans Kristian Moen VollanWellcome Trust Sanger Institute
Hans Kristian Moen VollanOslo University Hospital
Hans Kristian Moen VollanThe K.G. Jebsen Center for Breast Cancer Research, University of Oslo
Claire HardyWellcome Trust Sanger Institute
Olivia JosephWellcome Trust Sanger Institute
Laura MudieWellcome Trust Sanger Institute
Adam ButlerWellcome Trust Sanger Institute
Jon TeagueWellcome Trust Sanger Institute
Curtis GumbsM. D. Anderson Cancer Center, The University of Texas
Alexander J LazarM. D. Anderson Cancer Center, The University of Texas
Harshad S MahadeshwarM. D. Anderson Cancer Center, The University of Texas
Harshad S MahadeshwarM. D. Anderson Cancer Center, The University of Texas
Alexei ProtopopovM. D. Anderson Cancer Center, The University of Texas
Alexei ProtopopovM. D. Anderson Cancer Center, The University of Texas
Sahil SethM. D. Anderson Cancer Center, The University of Texas
Sahil SethM. D. Anderson Cancer Center, The University of Texas
Xingzhi SongM. D. Anderson Cancer Center, The University of Texas
Xingzhi SongM. D. Anderson Cancer Center, The University of Texas
Jiabin TangM. D. Anderson Cancer Center, The University of Texas
Jiabin TangM. D. Anderson Cancer Center, The University of Texas
Jianhua ZhangM. D. Anderson Cancer Center, The University of Texas
Jianhua ZhangM. D. Anderson Cancer Center, The University of Texas
Dina HalaiRoyal National Orthopaedic Hospital NHS Trust
Dina HalaiRoyal National Orthopaedic Hospital NHS Trust
Daniel BaumhoerInstitute of Pathology, University Hospital Basel, Institute for Applied Cancer Science
Roberto TiraboscoRoyal National Orthopaedic Hospital NHS Trust
Roberto TiraboscoRoyal National Orthopaedic Hospital NHS Trust
Fernanda AmaryRoyal National Orthopaedic Hospital NHS Trust
Fernanda AmaryRoyal National Orthopaedic Hospital NHS Trust
Ultan McDermottWellcome Trust Sanger Institute
Michael R StrattonWellcome Trust Sanger Institute
Phillip A FutrealWellcome Trust Sanger Institute
Phillip A FutrealM. D. Anderson Cancer Center, The University of Texas
Adrienne M FlanaganRoyal National Orthopaedic Hospital NHS Trust
Adrienne M FlanaganUniversity College London Cancer Institute
Adrienne M FlanaganRoyal National Orthopaedic Hospital NHS Trust
Adrienne M FlanaganUniversity College London Cancer Institute
Adrian L HarrisThe Weatherall Institute of Molecular Medicine, University of Oxford
Adrian L HarrisJohn Radcliffe Hospital
Peter J CampbellWellcome Trust Sanger Institute
Peter J CampbellAddenbrooke's Hospital
Peter J CampbellUniversity of Cambridge
  • 1 - 50

Datasets